A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
Clinical trial NCT05487391 · RECRUITING
Trial details
- NCT number
- NCT05487391
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2027-08-31
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.